VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

H. rhabdovirus DNA Vaccine encoding N and G
Vaccine Information
  • Vaccine Ontology ID: VO_0004567
  • Type: DNA vaccine
  • Status: Research
  • N nucleocapsid protein gene engineering:
    • Type: DNA vaccine construction
    • Detailed Gene Information: Click Here.
  • G glycoprotein gene engineering:
    • Type: DNA vaccine construction
    • Detailed Gene Information: Click Here.
  • Vector: pcDNA-G and pcDNA-N (Seo et al., 2006)
  • Immunization Route: Intramuscular injection (i.m.)
Host Response

Baboon Response

  • Vaccination Protocol: Five groups of forty flounder fry with a mean weight of 3 g were prepared for injection with pcDNA-G, pcDNA-N, a pcDNA-G and pcDNA-N mixture, pcDNA3.1(+) vector, or PBS (Seo et al., 2006).
  • Vaccine Immune Response Type: VO_0003057
  • Immune Response: Both cellular and humoral immune responses are involved in the protection of fish immunized with DNA vaccine. Induction of specific antibody response has been observed from rainbow trout immunized with rhabdovirus G protein constructs. However, despite high levels of protection, neutralizing antibodies could not be detected in all vaccinated fish at the time of challenge, or survivors of the challenge (Seo et al., 2006).
  • Challenge Protocol: At 21 days post vaccination, flounder fry injected with different DNA vaccines were challenged by immersion in water containing 1.2 × 10^4 TCID ml−1 HIRRV (Seo et al., 2006).
  • Efficacy: Groups injected with the mixed pcDNA-N+pcDNA-G vaccine showed only 2.5% cumulative mortality. Control groups injected with plasmid only or PBS only showed at least 95% mortality. These results demonstrated the protective effect of this DNA vaccine against HIRRV infection (Seo et al., 2006).
References
Seo et al., 2006: Seo JY, Kim KH, Kim SG, Oh MJ, Nam SW, Kim YT, Choi TJ. Protection of flounder against hirame rhabdovirus (HIRRV) with a DNA vaccine containing the glycoprotein gene. Vaccine. 2006; 24(7); 1009-1015. [PubMed: 16176849].